跳至主要内容
临床试验/NCT00160290
NCT00160290终止4 期

An Open, Randomized, Parallel Group, Single Center Study to Investigate the Effect of Lactulose Versus Plantago Ovate on the Quality of Life of Patients With Hard Stools and Hemorrhoids or Anal Fissure

Solvay Pharmaceuticals8 个研究点 分布在 1 个国家目标入组 97 人开始时间: 2002年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
97
试验地点
8
主要终点
Quality of life of patients with hard stools and hemorrhoids or anal fissure

研究概览

简要总结

To demonstrate that lactulose acts as a stool softener, relieving the pain at defecation, improving the number of defecations and regulating the colonic transit time in patients suffering of hemorrhoids or anal fissure. To compare efficacy and quality of life in patients treated either with lactulose or plantago ovate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients suffering from symptomatic hemorrhoids, or symptomatic anal fissure.

排除标准

  • Patients suffering from malignant tumor in the intestine or the anal-rectal region, irritable colon, intestine inflammatory disease.

研究组 & 干预措施

B

Active Comparator

Plantago Group

干预措施: Plantago ovata (Drug)

A

Experimental

Lactulose Group

干预措施: Lactulose (Drug)

结局指标

主要结局

Quality of life of patients with hard stools and hemorrhoids or anal fissure

时间窗: 6 weeks

次要结局

  • Gastrointestinal Symptoms Rating Scale(6 weeks)
  • Bristol stool consistency scale(6 weeks)
  • Number of episodes of rectal bleeding(6 weeks)
  • Need of rescue medication(6 weeks)

研究者

申办方类型
Industry

研究点 (8)

Loading locations...

相似试验